JBM (Healthcare) Limited (HKG:2161)

Market Cap	2.27B +58.6%
Revenue (ttm)	812.98M +12.8%
Net Income	216.39M +32.0%
EPS	0.25 +26.4%
Shares Out	817.30M
PE Ratio	11.29
Forward PE	9.46
Dividend	0.20 (7.17%)
Ex-Dividend Date	Nov 28, 2025

Volume	678,000
Average Volume	346,359
Open	2.730
Previous Close	2.720
Day's Range	2.730 - 2.800
52-Week Range	1.470 - 3.430
Beta	0.31
RSI	58.93
Earnings Date	Feb 16, 2026

About JBM (Healthcare)

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 412
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2161

Financial Performance

In fiscal year 2025, JBM (Healthcare)'s revenue was 782.29 million, an increase of 20.65% compared to the previous year's 648.42 million. Earnings were 197.26 million, an increase of 51.20%.